Elixinol Global Ltd (ELLXF)

Elixinol Global Ltd is a common stock listing on OTC Markets for Elixinol Wellness Limited, a holding company based in Newtown, Australia. The company operates across Australia, the Americas, and other international markets, with activities centered on human nutrition, human wellness, pet wellness, and superfood ingredients. Its product range is sold under brands including Hemp Foods Australia, Mt Elephant, The Healthy Chef, Soul Foods, Ananda Equine, and Field Day. Distribution is carried out through grocery, wholesale, and e-commerce channels, including supply to white label customers and manufacturers in the food, beverage, and beauty sectors. The company also manufactures and distributes hemp-derived cannabidiol (CBD) products. Incorporated in 2017, the business was formerly known as Elixinol Global Limited before changing its name to Elixinol Wellness Limited in May 2021.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
OTC-ELLX.F
$0.0079
-21.0% Downside
Overvalued
Not available
Not available
Fair
0.0%
December 2, 2026
0.5x
0.2x
2.21 M
4.106 M
40.4%
79.6%
-72.7
74.1%
Valuation • Fair Value

Elixinol Global Ltd (OTC-ELLX.F) Fair Value by Valuation Model

Review the available estimates for Elixinol Global Ltd (OTC-ELLX.F), including DCF Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$0.0079

Estimated downside of 21.0% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$0.0075

Discounted cash flow valuation reference.

Comps Fair Value

$0.0081

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 4 available valuation references for Elixinol Global Ltd (OTC-ELLX.F) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Elixinol Global Ltd (OTC-ELLX.F)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

11 M

Current operating scale indicator.

Revenue Forecast

11.253 M

Forward revenue estimate.

EBITDA

-1.443 M

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Elixinol Global Ltd (OTC-ELLX.F) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Elixinol Global Ltd (OTC-ELLX.F)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

2

Weak quality score that deserves closer review.

Beneish M-Score

-2.73

No elevated caution signal from this screen.

Altman Z-Score

-72.7

Lower score that deserves closer risk review.

FCF / Net Income

74.1%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Elixinol Global Ltd (OTC-ELLX.F). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Elixinol Global Ltd (OTC-ELLX.F)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

December 2, 2026

Days to Earnings

71

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Elixinol Global Ltd (OTC-ELLX.F), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Buy

The 15-minute technical read for Elixinol Global Ltd (OTC-ELLX.F) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Buy

The 1-hour technical read for Elixinol Global Ltd (OTC-ELLX.F) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for Elixinol Global Ltd (OTC-ELLX.F) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Buy

The weekly technical read for Elixinol Global Ltd (OTC-ELLX.F) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Elixinol Global Ltd (OTC-ELLX.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ Fast Investor Answers

Elixinol Global Ltd (OTC-ELLX.F) Stock FAQ

Data-supported answers about Elixinol Global Ltd (OTC-ELLX.F), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$0.0079
Estimated downside 21.0%
Valuation Rating
Overvalued
Estimated downside of 21.0%
Financial Health
Fair
Current financial-health read

The current fair value estimate for Elixinol Global Ltd (OTC-ELLX.F) is $0.0079. This implies an estimated downside of 21.0% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 21.0% versus the current market price.

The current financial health read for Elixinol Global Ltd (OTC-ELLX.F) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Elixinol Global Ltd (OTC-ELLX.F) is December 2, 2026.

The latest available data indicates no current dividend yield for Elixinol Global Ltd (OTC-ELLX.F).

The current market capitalization listed for Elixinol Global Ltd is 2.21 M.

The current enterprise value listed for Elixinol Global Ltd is 4.106 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Elixinol Global Ltd is OTC-ELLX.F, and the stock is listed on OTC Markets.

Elixinol Global Ltd (OTC-ELLX.F) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Elixinol Global Ltd is 40.4%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Elixinol Global Ltd is 79.6%. Free float helps investors understand how much of the share base is available for public trading.